Jasmin L, Arsenault P, Ohara PT, Marchand S (2000) Chronic noradrenergic spinal denervation in rats does not produce long-term hyperalgesia. Neuroscience 2000 Abstracts 243.7. Society for Neuroscience, New Orleans, LA.
Summary: Pharmacological studies have established that noradrenaline tonically inhibits spinal nociceptive transmission. We tested the hypothesis that chronically decreasing spinal noradrenaline would result in a disinhibition of nociceptive afferents resulting in behavioral hyperalgesia. We destroyed noradrenergic cells innervating the spinal cord using dopamine beta-hydroxylase antibodies linked to the neurotoxin saporin (anti-DBH-Sap). Male rats (n=6) were injected intrathecally with 4µg/10µl of anti-DBH-Sap, and their responses to nociceptive and non-nociceptive stimuli was monitored over a period of 65 days. Compared to controls (n=6), a significant (p< 0.05) decrease to hot plate (46oC) nociceptive responses could be observed during the first week post-treatment, but no differences were found at later times. At no point was there any altered response to innocuous stimuli. When tested for response to cold water stress, both treated and control animals showed analgesia, demonstrating that descending pain inhibition could still be activated. At 65 days, a formalin test showed no difference between treated (1.1 +/-0.5) and control (0.8 +/-0.5) groups. Post-mortem immunostaining of spinal cords for DBH, however, confirmed that noradrenergic denervation of the spinal cord had occurred in treated animals. These results suggest that a reorganization of the spinal cord following noradrenergic denervation is sufficient to reestablish normal nociceptive responses.
Related Products: Anti-DBH-SAP (Cat. #IT-03)